Infective Endocarditis in Moscow General Hospital: Clinical Characteristics and Outcomes (Single-Center 7 Years’ Experience)

Aim: to investigate clinical properties of course and outcomes of infective endocarditis (IE) depending on source of infection, to find predictors of mortality in a Moscow general hospital.

Materials and methods. We included in this study 176 patients with definite and possible infective endocarditis (the Duke criteria), admitted in our hospital in 2010–2017. Patients were divided in three groups according to source of infection. All patients underwent standard clinical and laboratory assessment, echocardiography, blood culture test combined with blood PCR with sequencing. Inhospital and 1­year outcome were evaluated.

Results. Among 176 patients with IE 65.3 % were men (median age 57 [35–72] years), most patients (n=149, 84.7 %) had native valve IE. Etiological factor was identified in 127 (72.2 %) cases. Gram­positive infective agents prevailed (54 %). Surgery in active phase of the disease was performed in 30 (17 %) patients. Among patients with healthcare­associated IE (n=76, 43.9 %) prevailed those older than 60 years, with high Charlson comorbidity index, with culture­negative IE, and complicated clinical course (mainly progressing heart failure). Patients with intravenous drug use associated IE (n=50, 28.4 %) had low Charlson index, association with hepatitis C viral infection, involvement of tricuspid valve with big vegetations, high frequency of embolic complications, and low inhospital mortality. Group of patients with community acquired IE (n=50, 28.4 %) more often had uncommon causative microorganisms, and had better long­term outcome. In­hospital mortality was 30.1 % (n=53) mostly due to sepsis with multi­organ failure, and heart failure. Risk factors of inhospital death were history of cardiovascular diseases, old age, kidney damage, methicillin­resistant Staphylococcus aureus (MRSA) infection, uncontrolled infection, and embolic events. Risk factors of 1­year mortality were history of stroke, and heart failure as IE complication. Independent predictors of in­hospital death were MRSA infection (odds ratio [OR] 50.32, 95 % confidence interval [CI] 1.66–213.92; p=0.002), persistent infection (OR 18.6, 95 %CI 5.37–64.40; p=0.001), duration of fever >7 days after initiation of antibacterial therapy (OR 13.41, 95 %CI 3.51–51.24; p=0.001); and of death during first year – history of cerebral infarction (OR 4.39, 95 %CI 1.32–14.70; p=0.016)), and heart failure as IE complication (OR 8.1, 95 %CI 1.97–67.09; p=0.016). Among patients subjected to surgery there were no fatal outcomes during 1 year after hospital discharge, while among conservatively treated patients were 21 (14.4 %) deaths (p<0.009).

Conclusion. Main clinical features of IE course in patients urgently admitted to a general hospital was dominance of healthcare­associated  IE among patients, who were older than 60 years with severe comorbidities. These patients had more complications and worse outcome. Modeling of prognosis identified uncontrolled infection as key factor of unfavorable outcome. Surgery significantly reduced long­term mortality.

1. Thuny F., Giorgi R., Habachi R. et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am HeartJ 2012;164 (1):94-101.

2. Ambrosioni J., Hernandez-Meneses M., Tellez A. et al.; Hospital Clinic Infective Endocarditis Investigators. Curr Infect Dis Rep 2017;19 (5):21. DOI: 10.1007/s11908-017-0574-9.

3. Murdoch D. R., Corey R. G., Hoen B. et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century The international collaboration on Endocarditis-prospective cohort study. Arch Intern Med 2009;169 (5):463-473.

4. Cahill T.J., Prendergast B. D. Infective endocarditis. Lancet 2016;387:882-893.

5. Federal State Statistics Service (Rosstat) www.gks.ru

6. Frank G. A. Formulating of a pathologo-anatomical diagnosis of certain infectious and parasitic diseases Class I “certain infectious and parasitic diseases" ICD-10. Practical medicine, 2016. 53 p. Russian

7. Nashef S. A. M., Roques F., Michel P. et al. European system for cardiac operative risk evaluation (EuroSCORE). EurJ Cardio-thoracic Surg 1999;16 (1):9-13.

8. Charlson M. E., Pompei P., Ales K. L., MacKenzie C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40 (5):373-383.

9. Mareyev V. Yu., Fomin I. V., Ageev F. T., Arutyunov G. P. Chronic heart failure (CHF). Clinical recommendations (2016). Available at: http://scardio.ru/content/Guidelines/SSHF-Guidelines-rev.4.0.1.pdf. Checked by Apr 16, 2018. Russian http: //scardio.ru/content/Guidelines/SSHF-Guidelines-rev.4.0.1.pdf.

10. Eknoyan G., Lameire N. Eckardt K-U et al. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney international supplements 2013;3 (1):1-150

11. Kotova E. O., Domonova E. A., Karaulova Y. L. et al. Infective endocarditis: Importance of molecular biological techniques in etiological diagnosis. Terapevticheskii Arkhiv 2016;88 (11):62-67. Russian

12. Pant S., Patel N.J., Deshmukh A. et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 2015;65 (19):2070-2076.

13. Tiurin V. P. Infectious endocaditis. GEOTAR-Media, 2012. 368 p. Russian

14. Munoz P., Kestler M., De A. A. et al. Current Epidemiology and Outcome of Infective Endocarditis: A Multicenter, Prospective, Cohort Study. Medicine 2015;94 (43):1-8.

15. Fernandez-Hidalgo N. D., Almirante B. B, Tornos P. P. et al. Contemporary epidemiology and prognosis of health care-associated infective endocarditis. Clin Infect Dis 2008;47 (10):1287-1297.

16. Pisaryuk A. S., Chukalin A. S., Sorokina M. A. et al. Infectious endocarditis caused by Gemella haemolysans: clinical issues and treatment approaches. Clinical Microbiology and Antimicrobial Chemotherapy 2017;19 (4):335-340. Russian

17. Skopin I. I., Samorodskaya I. V., Umarov V. M. et al. Immediate and long-term results of surgical treatment of active infective endocarditis of native heart valves in drug-dependent patients. Annaly Khirurgii 2013; (3):35-42. Russian

18. Kotova E. O., Pisaryuk A. S., Getiya T. S. et al. Contemporary infective endocarditis: acute kidney injury as a manifestation of cardiorenal syndrome. Klinicheskaya farmakologya i terapiya 2015; 24 (2):47-53. Russian

19. Habib G., Lancellotti P., Antunes M.J. et al. 2015 ESC Guidelines for the management of infective endocarditis. Eur Hear J 2015;36:3075-3123

20. Drobysheva V. P., Demin A. A., Fridman Ye. S. Renal injury in infective endocarditis. Sibirskii Medicinskii Zhurnal (Irkutsk) 2009;3 (1):79-82. Russian

21. Muratov R. M., Amiragov R. I., Babenko S. I. Infective endocarditis. Clinical recommendations of the ministry of health of the Russian Federation. 2016;50. Russian